Back to top
more

VERADIGM INC (MDRX)

(Real Time Quote from BATS)

$7.51 USD

7.51
84,441

+0.01 (0.07%)

Updated May 15, 2024 03:54 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 23% (58 out of 250)

Industry: Technology Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for MDRX

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

0 items in cart

Veradigm Inc. [MDRX]

Reports for Purchase

Showing records 541 - 560 ( 600 total )

Company: Veradigm Inc.

Industry: Medical Info Systems

Record: 541

02/09/2014

Industry Report

Pages: 4

Healthcare Facilities - Latest Bipartisan SGR Fix Does Not Extend Payments for Rural Hospitals

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 10.00

Research Provided by a Third Party

Company: Veradigm Inc.

Industry: Medical Info Systems

Record: 542

01/14/2014

Company Report

Pages: 6

Management Breaks its Silence

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 25.00

Research Provided by a Third Party

Company: Veradigm Inc.

Industry: Medical Info Systems

Record: 543

12/16/2013

Company Report

Pages: 6

Updating Model Estimates to Reflect the Movement to SaaS

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 25.00

Research Provided by a Third Party

Company: Veradigm Inc.

Industry: Medical Info Systems

Record: 544

12/08/2013

Industry Report

Pages: 2

Meaningful Use Extension Adds Downside Risk to 2014 Estimates

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 10.00

Research Provided by a Third Party

Company: Veradigm Inc.

Industry: Medical Info Systems

Record: 545

11/08/2013

Company Report

Pages: 7

Price: 24.95

Company: Veradigm Inc.

Industry: Medical Info Systems

Record: 546

11/07/2013

Daily Note

Pages: 3

Quick Alert: Is It Really Only About Bookings?

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 10.00

Research Provided by a Third Party

Company: Veradigm Inc.

Industry: Medical Info Systems

Record: 547

11/06/2013

Company Report

Pages: 6

Taking Caution and Setting the Bar Low

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 25.00

Research Provided by a Third Party

Company: Veradigm Inc.

Industry: Medical Info Systems

Record: 548

11/01/2013

Daily Note

Pages: 3

Allscripts Wins an Endorsement for Its Population Health Offerings

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 10.00

Research Provided by a Third Party

Company: Veradigm Inc.

Industry: Medical Info Systems

Record: 549

10/09/2013

Daily Note

Pages: 17

Healthcare Information Technology (HCIT): 3Q13 Preview

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 50.00

Research Provided by a Third Party

Company: Veradigm Inc.

Industry: Medical Info Systems

Record: 550

09/19/2013

Company Report

Pages: 7

Price: 24.95

Company: Veradigm Inc.

Industry: Medical Info Systems

Record: 551

09/05/2013

Daily Note

Pages: 12

Morning Meeting Notes

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: Veradigm Inc.

Industry: Medical Info Systems

Record: 552

09/04/2013

Company Report

Pages: 28

Initiating Coverage with a HOLD Rating

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 75.00

Research Provided by a Third Party

Company: Veradigm Inc.

Industry: Medical Info Systems

Record: 553

05/15/2013

Company Report

Pages: 8

Price: 24.95

Company: Veradigm Inc.

Industry: Medical Info Systems

Record: 554

02/21/2013

Company Report

Pages: 8

Price: 24.95

Company: Veradigm Inc.

Industry: Medical Info Systems

Record: 555

11/17/2012

Company Report

Pages: 8

Price: 24.95

Company: Veradigm Inc.

Industry: Medical Info Systems

Record: 556

08/22/2012

Company Report

Pages: 8

Price: 24.95

Company: Veradigm Inc.

Industry: Medical Info Systems

Record: 557

06/07/2012

Daily Note

Pages: 5

Termination of Coverage

Provider: AURIGA USA

Price: 10.00

Research Provided by a Third Party

Company: Veradigm Inc.

Industry: Medical Info Systems

Record: 558

05/17/2012

Company Report

Pages: 8

Price: 24.95

Company: Veradigm Inc.

Industry: Medical Info Systems

Record: 559

04/27/2012

Company Report

Pages: 5

Allscripts Lays an Egg on Warning; Reducing Target to $14

Provider: AURIGA USA

Analyst: MANNHEIMER G

Price: 10.00

Research Provided by a Third Party

Company: Veradigm Inc.

Industry: Medical Info Systems

Record: 560

03/29/2012

Company Report

Pages: 9

Too Little, Too Late; Downgrading to HOLD, Cutting Price Target to $19

Provider: AURIGA USA

Analyst: MANNHEIMER G

Price: 25.00

Research Provided by a Third Party